455
Views
4
CrossRef citations to date
0
Altmetric
Clinical

Tracheostomy ventilation in motor neurone disease: a snapshot of UK practice

, &
Pages 35-41 | Received 12 Jan 2021, Accepted 23 Mar 2021, Published online: 08 May 2021

References

  • Gil J, Funalot B, Verschueren A, Danel-Brunaud V, Camu W, Vandenberghe N, et al. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol. 2008;15:1245–51.
  • Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006;5:140–7.
  • Sancho J, Martinez D, Bures E, Diaz JL, Ponz A, Servera E. Bulbar impairment score and survival of stable amyotrophic lateral sclerosis patients after non-invasive ventilation initiation. ERJ Open J. 2018;4:1–10.
  • Naoki H, Naoki A, Daichi Y, Ryoichi N, Masahiro N, Masahisa K, et al. Prognosis of amyotrophic lateral sclerosis patients undergoing tracheostomy invasive ventilation therapy in Japan. J Neurol Neurosurg Psychiatry. 2020;91:285–90.
  • National Institute for Health and Care Excellence. Motor neurone disease: assessment and management NICE guideline [NG42]. 2016. Available at: https://www.nice.org.uk/. Accessed December 2019.
  • Sancho J, Servera E, Diaz JL, Banuls P, Marin J. Home tracheotomy mechanical ventilation in patients with amyotrophic lateral sclerosis: causes, complications and 1-year survival. Thorax. 2011;66:948–52.
  • Kaub-Wittemer D, Steinbuchel N, Wasner M, Laier-Groeneveld G, Borasio GD. Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. J Pain Symptom Manage. 2003;26:890–6.
  • Marchese S, Lo Coco D, Lo Coco A. Outcome and attitudes toward home tracheostomy ventilation of consecutive patients: a 10-year experience. Respir Med. 2008;102:430–6.
  • Vianello A, Arcaro G, Palmieri A, Ermani M, Braccioni F, Gallan F, et al. Survival and quality of life after tracheostomy for acute respiratory failure in patients with amyotrophic lateral sclerosis. J Crit Care. 2011;26:329.e7–14.
  • Takei K, Tsuda K, Takahashi F, Hirai M, Palumbo J. An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:88–97.
  • American Academy of Neurology. Update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies. 2009. Available at: https://www.aan.com/guidelines/home/guidelinedetail/370. Accessed December 2019.
  • The EFNS Taskforce on Diagnosis and Management of Amyotrophic Lateral Sclerosis. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS) – revised report of an EFNS Task Force. Eur J Neurol. 2012;9:360–75.
  • Turner MR, Faull C, McDermott C, Nickol A, Palmer J, Talbot K. Tracheostomy in motor neuron disease. Pract Neurol. 2019;19:467–75.
  • Hirose T, Kimura F, Tani H, Ota S, Tsukahara A, Sano E, et al. Clinical characteristics of long-term survival with noninvasive ventilation and factors affecting the transition to invasive ventilation in amyotrophic lateral sclerosis. Muscle Nerve. 2018;58:770–6.
  • Chio A, Calvo A, Ghiglione P, Mazzini L, Mutani R, Mora G, et al. Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy. J Neurol Neurosurg Psychiatry. 2010;81:1141–3.
  • Asai H, Hirano M, Udaka F, Shimada K, Oda M, Kubori T, et al. Sympathetic disturbances increase risk of sudden cardiac arrest in sporadic ALS. J Neurol Sci. 2007;254:78–83.
  • Tagami M, Kimura F, Nakajima H, Ishida S, Fujiwara S, Doi Y, et al. Tracheostomy and invasive ventilation in Japanese ALS patients: decision-making and survival analysis: 1990–2010. J Neurol Sci. 2014;344:158–64.
  • National Institute for Health and Care Excellence. Guidance on the use of Riluzole (Rilutek) for the treatment of motor neurone disease (TA20). 2001. Available at: https://www.nice.org.uk/guidance/ta20. Accessed March 2021.
  • Hirano Y, Yamazaki Y. Illness experiences of invasive mechanical ventilator-dependent amyotrophic lateral sclerosis patients in Japan: a study of trajectories and correlates of psychological well-being. Jpn J Health Hum Ecol. 2009;75:79–89.
  • Palmer J, Armstrong A, Kathiresan B, Latham M, Moses R. S41 tracheostomy ventilation in motor neurone disease: a multi-centre review. Thorax. 2017;72:A28.2–A28.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.